	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	209.23	258.43	396.46	455.45	487.12	619.63	717.16	772.77
Cost of Operating Revenue	42.98	60.13	121.19	101.68	127.96	227.76	272.99	269.51
Gross Profit	166.26	198.29	275.27	353.77	359.16	391.88	444.17	503.27
Gross Margin	79.5	76.7	69.4	77.7	73.7	63.2	61.9	65.1
Total Operating Expenses	176.95	228.02	339.58	365.11	417.88	549.88	615.32	651.36
Operating Profit	32.28	30.41	56.88	90.34	69.24	69.75	101.84	121.41
Operating Margin	15.4	11.8	14.3	19.8	14.2	11.3	14.2	15.7
Financing Income/(Expense) - Net	-15.53	-12.84	-14.00	-3.84	9.99	0.27	-7.95	-34.36
Profit before Taxes	-77.73	-158.33	295.45	86.51	80.20	70.01	102.69	130.37
Income Taxes	-19.67	-46.38	110.52	18.12	18.09	13.17	25.08	28.94
Profit after Tax	-58.06	-111.95	184.93	68.39	62.11	56.84	77.61	101.43
PAT Margin	-27.7	-43.3	46.6	15.0	12.8	9.2	10.8	13.1
EPS - Basic - ex Extraordinary Items	-18.49	-35.66	58.90	22.89	19.78	17.90	24.03	31.30
EPS - Diluted - ex Extraordinary Items	-18.49	-35.66	58.90	22.88	19.29	17.31	23.56	30.88
EBIT	32.28	30.41	56.88	90.34	69.24	69.75	101.84	121.41
EBITDA	57.92	62.82	94.32	131.72	123.02	144.30	190.17	211.87
EBITDA Margin	27.7	24.3	23.8	28.9	25.3	23.3	26.5	27.4

Balance Sheet

Abridged

Understanding Balance Sheet

Krsnaa Diagnostics Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	C 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	PR	PR	PR	AR	AR	AR	AR	PRESS
Total Current Assets	189	214	248	334	223	421	414	738
Long-Term Investments	15	6	2	116	155	15	98	36
Property Plant & Equipment - Net	264	283	311	412	493	655	670	860
Total Non-Current Assets	340	416	356	542	687	751	867	1,085
Total Assets	529	630	605	876	910	1,172	1,282	1,824
Total Current Liabilities	173	181	184	149	99	281	305	275
Long Term Debt	410	618	168	33	24	42	47	468
Total Non-Current Liabilities	441	646	189	43	72	81	93	568
Total Liabilities	614	827	373	192	171	362	399	843
Total Shareholders' Equity	-85	-197	232	684	739	810	883	980
Total Equity	-85	-197	232	684	739	810	883	980
Total Liabilities & Equity	529	630	605	876	910	1,172	1,282	1,824

Cash Flow

Abridged

Understanding Cash Flow Statement

Krsnaa Diagnostics Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	40.52	40.08	71.70	126.08	116.68	119.10	177.59	171.64
Working Capital - Increase/(Decrease)	3.37	-19.32	14.83	-0.66	-35.58	-96.78	-93.44	-46.64
Net CF from Operating Activities	43.89	20.76	86.54	125.42	81.10	22.32	84.15	125.00
Capital Expenditures - Net	99.78	76.75	64.84	131.13	134.73	193.00	111.71	215.57
Net CF from Investing Activities	-200.72	-84.02	-70.54	-257.59	-119.03	-139.26	-117.52	-404.47
Dividends Paid - Cash - Total	-	-	-	-	7.85	8.63	8.07	8.92
Stock - Issuance/(Retirement) - Net	100.00	-	0.73	400.00	-	23.19	-	3.75
Debt - LT & ST - Issuance/(Retirement) - Total	44.15	30.25	55.53	-189.37	-13.10	82.03	42.91	311.01
Net Cash Flow from Financing Activities	140.11	30.19	56.26	195.95	-27.80	96.59	34.84	305.84
Free Cash Flow to Equity	-11.74	-25.74	77.22	-195.08	-66.73	-88.65	15.35	220.44
Free Operating CF net dividend	-55.89	-55.99	19.70	-6.80	-68.11	-180.19	-50.55	-103.18
Free Operating CF	-55.89	-55.99	19.70	-6.80	-60.26	-171.57	-42.47	-94.26

Business Segment Analysis

FY End:

Mar 25

Krsnaa Diagnostics Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Diagnostic services (100.0%)₹ 126.63 Cr

Revenue / Sales

Diagnostic services (100.0%)₹ 717.16 Cr

Assets

Diagnostic services (100.0%)₹ 1,281.60 Cr

Operating Income

Diagnostic services (100.0%)₹ 101.84 Cr

Regional Segment Analysis

Krsnaa Diagnostics Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Krsnaa Diagnostics Ltd.

Historical Segment Analysis

Track how Krsnaa Diagnostics Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Diagnostic services	100	77	67	132	141	194	127

Frequently Asked Questions

What is the revenue of Krsnaa Diagnostics Ltd.?

The latest trailing twelve month revenue of Krsnaa Diagnostics Ltd. is ₹ 772.77 Cr, reflecting a 1-year growth of 7.75% and a 3-year CAGR of 16.63%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Krsnaa Diagnostics Ltd.?

The latest trailing twelve month net profit (PAT) of Krsnaa Diagnostics Ltd. is ₹ 101.43 Cr, with a 3-year earnings CAGR of 16.98%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Krsnaa Diagnostics Ltd.?

The trailing twelve month EBITDA of Krsnaa Diagnostics Ltd. is approximately ₹ 121.41 Cr (based on an operating margin of 15.71%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Krsnaa Diagnostics Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Krsnaa Diagnostics Ltd. is 30.88. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Krsnaa Diagnostics Ltd.?

The debt-to-equity ratio of Krsnaa Diagnostics Ltd. stands at 0.55. The interest coverage ratio is 3.53x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Krsnaa Diagnostics Ltd.?

The estimated book value per share of Krsnaa Diagnostics Ltd. is 301.22 (derived from a P/B ratio of 1.90 and market price of ₹ 571.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Krsnaa Diagnostics Ltd.?

The trailing twelve month operating cash flow of Krsnaa Diagnostics Ltd. is ₹ 125.00 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Krsnaa Diagnostics Ltd. report consolidated or standalone financials?

Krsnaa Diagnostics Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.